Sfoglia per AUTORE
MENEGATTI E
Collezione ASL Città di Torino

  

Items : 10

Pediatric Presentation of Antiphospholipid Syndrome: A Review of Recent Literature With Estimation of Local Prevalence. in Seminars in thrombosis and hemostasis / Semin Thromb Hemost. 2024 Mar;50(2):182-187. doi: 10.1055/s-0043-1764472. Epub 2023 Mar 20.
2024
ASL Città di Torino

Radin M; Cecchi I; Arbrile M; Montin D; Farinasso L; Cioffi M; Foddai SG; Barinotti A; Menegatti E; Baldovino S; Sciascia S; Roccatello D;

Safety and efficacy of pre-exposure prophylaxis with tixagevimab/cilgavimab (Evusheld) in patients with glomerular diseases who received rituximab. in Clinical kidney journal / Clin Kidney J. 2023 May 15;16(9):1465-1468. doi: 10.1093/ckj/sfad111. eCollection 2023 Sep.
2023
ASL Città di Torino

Sciascia S; Rilat MLA; Fenoglio R; Foddai SG; Radin M; Cecchi I; Cinnirella G; Crosasso P; Guidetti MG; Barinotti A; Baldovino S; Menegatti E; Roccatello D;

Open-label, prospective, phase II descriptive pilot trial of belimumab therapy for refractory and/or non-criteria manifestations of antiphospholipid syndrome: study protocol. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2023 Mar;41(3):597-604. doi: 10.55563/clinexprheumatol/qa2yb4. Epub 2022 Oct 28.
2023
ASL Città di Torino

Sciascia S; Radin M; Cecchi I; Barinotti A; Rubini E; Rossi D; Fenoglio R; Vaccarino A; Menegatti E; Roccatello D; Sciascia S; Radin M; Cecchi I; Barinotti A; Rubini E; Rossi D; Fenoglio R; Vaccarino A; Menegatti E; Roccatello D;

Tailoring Tofacitinib Oral Therapy in Rheumatoid Arthritis: The TuTOR App. in International journal of environmental research and public health / Int J Environ Res Public Health. 2022 Apr 28;19(9):5379. doi: 10.3390/ijerph19095379.
2022
ASL Città di Torino

Radin M; Arbrile M; Cecchi I; Di Nunzio P; Buccarano N; Di Gregorio F; Milone V; Osella S; Crosasso P; Favuzzi MD; Barinotti A; Baldovino S; Menegatti E; Rossi D; Sciascia S; Roccatello D;

Cerebrovascular events in patients with isolated anti-phosphatidyl-serine/prothrombin antibodies. in Immunologic research / Immunol Res. 2021 Aug;69(4):372-377. doi: 10.1007/s12026-021-09208-1. Epub 2021 Jul 10.
2021
ASL Città di Torino

Radin M; Barinotti A; Foddai SG; Cecchi I; Rubini E; Roccatello D; Menegatti E; Sciascia S;

Vedolizumab for the Management of Refractory Behçet's Disease: From a Case Report to New Pieces of Mosaic in a Complex Disease. in Frontiers in immunology / Front Immunol. 2021 Oct 25;12:769785. doi: 10.3389/fimmu.2021.769785. eCollection 2021.
2021
ASL Città di Torino

Arbrile M; Radin M; Rossi D; Menegatti E; Baldovino S; Sciascia S; Roccatello D;

2015
ASL Città di Torino

Roccatello D; Sciascia S; Baldovino S; Rossi D; Alpa M; Naretto C; Di Simone D; Simoncini M; Menegatti E;

Rituximab in cryoglobulinemic peripheral neuropathy. in Journal of neurology / J Neurol. 2009 Jul;256(7):1076-82. doi: 10.1007/s00415-009-5072-z. Epub 2009 Mar 5.
2009
ASL Città di Torino

Cavallo R; Roccatello D; Menegatti E; Naretto C; Napoli F; Baldovino S;

Anti-neuronal antibodies in patients with HCV-related mixed cryoglobulinemia. in Autoimmunity reviews / Autoimmun Rev. 2008 Oct;8(1):56-8. doi: 10.1016/j.autrev.2008.07.027. Epub 2008 Aug 12.
2008
ASL Città di Torino

Alpa M; Ferrero B; Cavallo R; Naretto C; Menegatti E; Di Simone D; Napoli F; La Grotta R; Rossi D; Baldovino S; Sena LM; Roccatello D;

Effects of ANCA-positive sera on the generation of oxygen free radicals by neutrophils. in Contributions to nephrology / Contrib Nephrol. 1992;99:108-13. doi: 10.1159/000421698.
1992
ASL Città di Torino

Rollino C; Roccatello D; Cavalli G; Amprimo MC; Quattrocchio G; Menegatti E; Mediate I; Ferrero A; Basolo B; Ferro M; et al;